Phathom Pharmaceuticals, Inc. (PHAT) Earnings Per Share (EPS)
Phathom Pharmaceuticals, Inc. (PHAT) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | -$3.88 |
| 2021-12-31 | -$3.89 |
| 2022-12-31 | -$5.05 |
| 2023-12-31 | -$3.93 |
| 2024-12-31 | -$5.29 |
| 2025-12-31 | -$3.03 |
How PHAT compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ALEC | Alector Inc. | -$1.39 |
| XBIT | XBiotech Inc. | -$1.49 |
| VERU | Veru Inc. | -$1.55 |
| VTGN | Vistagen Therapeutics Inc. | -$1.83 |
| EYPT | EyePoint Pharmaceuticals Inc. | -$3.17 |
These are five companies in the same sector as PHAT with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Phathom Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("PHAT")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PHAT | $9.27 | -3.13% | 0.37M |
| 3 | ||||
| 4 | ||||
| 5 |